Azacitidine for treating AML or MDS relapsed after HSCT; a single-center study

Yuka Kawaguchi

Presentation information

Poster Session

Sun.Oct,13

Poster Session 3-17 Post-transplant: Relapse/Secondary Malignancy/Others

Sun. Oct 13, 2019 1:20 PM - 2:00 PM Poster (Tokyo International Forum, B2F Hall E)

Chair: Nobuharu Fujii (Department of Transfusion Medicine, Okayama University Hospital)

[PS3-17-3] Azacitidine for treating AML or MDS relapsed after HSCT; a single-center study

Yuka Kawaguchi, Kohei Ishigiwa, Kenichiro Takeda, Yosuke Domon, Tomoe Ichiki, Motohito Okabe, Rena Matsumoto, Marie Ohbiki, Masahide Osaki, Tatsunori Goto, Takanobu Morishita, Yukiyasu Ozawa, Koichi Miyamura (Hematol., Japan Red Cross Nagoya First Hospital, Nagoya, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.